Anthony Johnson

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Anthony L. Johnson or Tony Johnson is a statistician and co-author of a number of PACE trial publications.[1]

Notable studies[edit | edit source]

PACE trial publications include:

Main trial outcome
Other PACE trial publications

Letters[edit | edit source]

PACE trial authors' responses

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

  • PubMed
  • Twitter
  • Facebook
  • Website
  • YouTube

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ Medical Research Council. "About the Biostatistics Unit | History of Achievements". MRC Biostatistics Unit. Retrieved January 31, 2019.
  2. ↑ White, PD; Goldsmith, KA; Johnson, AL; Potts, L; Walwyn, R; DeCesare, JC; Baber, HL; Burgess, M; Clark, LV; Cox, DL; Bavinton, J; Angus, BJ; Murphy, G; Murphy, M; O'Dowd, H; Wilks, D; McCrone, P; Chalder, T; Sharpe, M; The PACE Trial Management Group (March 5, 2011). "Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial". The Lancet. 377 (9768): 823–836. doi:10.1016/S0140-6736(11)60096-2. PMID 21334061.
  3. ↑ McCrone, P; Sharpe, M; Chalder, T; Knapp, M; Johnson, AL; Goldsmith, K (August 1, 2012). "Adaptive Pacing, Cognitive Behaviour Therapy, Graded Exercise, and Specialist Medical Care for Chronic Fatigue Syndrome: A Cost-Effectiveness Analysis". PLoS One. doi:10.1371/journal.pone.0040808. PMID 22870204.
  4. ↑ White, PD; Goldsmith, K; Johnson, AL; Chalder, T; Sharpe, M; PACE Trial Management Group (October 2013). "Recovery from chronic fatigue syndrome after treatments given in the PACE trial". Psychol Med. 43 (10): 2227–2235. doi:10.1017/S0033291713000020. PMID 3776285.
  5. ↑ Walwyn, R; Potts, L; McCrone, P; Johnson, AL; DeCesare, JC; Baber, HL; Goldsmith, KA; Sharpe, M; Chalder, T; White, PD (November 13, 2013). "A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan". Trials Journal. doi:10.1186/1745-6215-14-386.
  6. ↑ Dougall, D; Johnson, A; Goldsmith, K; Sharpe, M; Angus, B; Chalder, T; White, P (July 2014), "Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome", Journal of Psychosomatic Research, 77 (1): 20–26, doi:10.1016/j.jpsychores.2014.04.002
  7. ↑ Sharpe, M; Goldsmith, KA; Johnson, AL; Chalder, T; Walker, J; White, PD (October 27, 2015). "Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial". The Lancet Psychiatry. 2: 1067–74. doi:10.1016/S2215-0366(15)00317-X. PMID 26521770. There was little evidence of differences in outcomes between the randomised treatment groups at long-term follow-up.
  8. ↑ White, PD; Goldsmith, KA; Johnson, AL; Walwyn, R; Baber, HL; Chalder, T; Sharpe, M (May 17, 2011). "(correspondence) The PACE trial in chronic fatigue syndrome – Authors' reply". The Lancet. 377 (9780): 1834–1835. doi:10.1016/S0140-6736(11)60651-X.
  9. ↑ Sharpe, M; Goldsmith, KA; Johnson, AL; Chalder, T; Walker, J; White, PD (February 2016), "(correspondence) Authors' reply - Patient reaction to the PACE trial", The Lancet Psychiatry, 3 (2): e8–e9, doi:10.1016/S2215-0366(16)00018-3
  10. ↑ White, PD; Chalder, T; Sharpe, M; Angus, BJ; Baber, HL; Bavinton, J; Burgess, M; Clark, LV; Cox, DL; DeCesare, JC; Goldsmith, KA; Johnson, AL; McCrone, P; Murphy, G; Murphy, M; O'Dowd, H; Potts, L; Walwyn, R; Wilks, D (January 2017). "Response to the editorial by Dr Geraghty". Journal of Health Psychology. 22 (9): 1113–1117. doi:10.1177/1359105316688953.

PACE trial A controversial study which claimed that CBT and GET were effective in treating "CFS/ME", despite the fact that its own data did not support this conclusion. Its results and methodology were widely disputed by patients, scientists, and the peer-reviewed scientific literature.

somatic symptom disorder A psychiatric term to describe an alleged condition whereby a person's thoughts somehow cause physical symptoms. The actual existence of such a condition is highly controversial, due to a lack of scientific evidence. It is related to other psychiatric terms, such as "psychosomatic", "neurasthenia", and "hysteria". Older terms include "somatization", "somatoform disorder", and "conversion disorder". Such terms refer to a scientifically-unsupported theory that claims that a wide range of physical symptoms can be created by the human mind, a theory which has been criticized as "mind over matter" parapsychology, a pseudoscience.

Retrieved from "https://me-pedia.org/w/index.php?title=Anthony_Johnson&oldid=239796"